These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24038224)

  • 1. Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.
    Marsón ME; Dana DD; Altcheh J; García-Bournissen F; Mastrantonio G
    J Clin Lab Anal; 2013 Sep; 27(5):384-90. PubMed ID: 24038224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.
    Perin L; Moreira da Silva R; Fonseca KD; Cardoso JM; Mathias FA; Reis LE; Molina I; Correa-Oliveira R; Vieira PM; Carneiro CM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease.
    Guerrero L; Pinazo MJ; Posada E; Gascón J; Ribas J; Soy D
    Clin Chem Lab Med; 2011 Jan; 49(1):77-82. PubMed ID: 21083440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and sensitive ultra-high-pressure liquid chromatography method for quantification of antichagasic benznidazole in plasma: application in a preclinical pharmacokinetic study.
    Davanço MG; de Campos ML; Peccinini RG
    Biomed Chromatogr; 2015 Jul; 29(7):1008-15. PubMed ID: 25424984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a LC-MS/MS methodology for the monitoring of the antichagasic drug benznidazole in human urine.
    Martínez N; Marson ME; Mastrantonio GE; Raba J; Cerutti S
    Talanta; 2015 Jan; 131():656-60. PubMed ID: 25281155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and efficient HPLC method for benznidazole dosage in human breast milk.
    Marson ME; Padró JM; Reta MR; Altcheh J; García-Bournissen F; Mastrantonio G
    Ther Drug Monit; 2013 Aug; 35(4):522-6. PubMed ID: 23851912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of benznidazole in adult patients with Chagas disease.
    Soy D; Aldasoro E; Guerrero L; Posada E; Serret N; Mejía T; Urbina JA; Gascón J
    Antimicrob Agents Chemother; 2015; 59(6):3342-9. PubMed ID: 25824212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.
    Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
    García MC; Manzo RH; Jimenez-Kairuz AF
    Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
    Altcheh J; Moscatelli G; Mastrantonio G; Moroni S; Giglio N; Marson ME; Ballering G; Bisio M; Koren G; García-Bournissen F
    PLoS Negl Trop Dis; 2014 May; 8(5):e2907. PubMed ID: 24853169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
    Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference of effective antitrypanosomal dosages of benznidazole in mice and man. Chemotherapeutic and pharmacokinetic results.
    Richle RW; Raaflaub J
    Acta Trop; 1980 Sep; 37(3):257-61. PubMed ID: 6106364
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography-Mass Spectrometry to Monitor Adherence to
    Momper JD; Hanan NJ; Rossi SS; Mirochnick MH; Cafferata ML; Lavenia A; Flores I; Gibbons L; Ciganda A; Sosa Estani S; Capparelli EV; Buekens P
    Am J Trop Med Hyg; 2019 Jul; 101(1):116-122. PubMed ID: 31115303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease.
    García-Bournissen F; Moroni S; Marson ME; Moscatelli G; Mastrantonio G; Bisio M; Cornou L; Ballering G; Altcheh J
    Arch Dis Child; 2015 Jan; 100(1):90-4. PubMed ID: 25210104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.
    Moreira da Silva R; Oliveira LT; Silva Barcellos NM; de Souza J; de Lana M
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3344-8. PubMed ID: 22450981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an ionic liquid-based dispersive liquid-liquid microextraction method for the determination of nifurtimox and benznidazole in human plasma.
    Padró JM; Marsón ME; Mastrantonio GE; Altcheh J; García-Bournissen F; Reta M
    Talanta; 2013 Mar; 107():95-102. PubMed ID: 23598198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of photostability and compatibility of the anti-chagas drug Benznidazole with pharmaceutics excipients.
    Santos FL; Rolim LA; Figueirêdo CB; Lyra MA; Peixoto MS; Ferraz LR; Soares-Sobrinho JL; Neves de Lima ÁA; Lima Leite AC; Rolim Neto PJ
    Drug Dev Ind Pharm; 2015 Jan; 41(1):63-9. PubMed ID: 24134564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
    Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
    Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.